The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Albemarle Corp

NYSE: ALB
Last

(U.S.) $49.00

Today's change-1.09 -2.18%
Updated February 11 10:40 AM EST. Delayed by at least 15 minutes.
 

Albemarle Corp

NYSE: ALB
Last

(U.S.) $49.00

Today's change-1.09 -2.18%
Updated February 11 10:40 AM EST. Delayed by at least 15 minutes.

Albemarle Corp crosses below 125-day moving average

Albemarle Corp is sharply lower today, dropping (U.S.)$1.09 or 2.18% to (U.S.)$49.00 and crossing below its 125-day moving average. Over the last five days, shares have lost 5.68% and are down 12.52% for the last year to date. This security has outperformed the S&P 500 by 4.01% during the last year.

Key company metrics

  • Open(U.S.) $48.78
  • Previous close(U.S.) $50.09
  • High(U.S.) $50.46
  • Low(U.S.) $48.42
  • Bid / Ask(U.S.) $49.00 / (U.S.) $49.04
  • YTD % change-12.52%
  • Volume193,399
  • Average volume (10-day)1,660,102
  • Average volume (1-month)1,433,681
  • Average volume (3-month)1,451,684
  • 52-week range(U.S.) $41.37 to (U.S.) $64.99
  • Beta1.94
  • Trailing P/E40.18×
  • P/E 1 year forward13.41×
  • Forward PEG3.04×
  • Indicated annual dividend(U.S.) $1.16
  • Dividend yield2.37%
  • Trailing EPS(U.S.) $1.22
Updated February 11 10:40 AM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+4.06%

Based on its net profit margin of 4.06%, Albemarle Corp is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX1.25%Sector:Basic MaterialsIndustry:Chemicals - Commodity
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue905931884599
Total other revenue--------
Total revenue905931884599
Gross profit312301258162
Total cost of revenue593631626436
Total operating expense792828848622
Selling / general / administrative138148136144
Research & development25252621
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)36246020
Other operating expenses, total--------
Operating income11310337-23
Interest income (expense), net non-operating-32-33-36-15
Gain (loss) on sale of assets--------
Other--------
Income before tax827151-49
Income after tax655437-21
Income tax, total171714-28
Net income655243-19
Total adjustments to net income--------
Net income before extra. items655243-17
Minority interest-5-7-4-4
Equity in affiliates66108
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items655243-17
Inc. avail. to common incl. extra. items655243-19
Diluted net income655243-19
Dilution adjustment--------
Diluted weighted average shares11311310879
Diluted EPS excluding extraordinary itemsvalue per share0.580.460.40-0.22
Dividends per sharevalue per share0.290.290.290.27
Diluted normalized EPSvalue per share0.830.630.79-0.05